Literature DB >> 4310724

Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4310724      PMCID： PMC2554752     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  21 in total

1.  Enterovirus studies in connection with the 1959 poliomyelitis epidemic in Hungary.

Authors:  I DOMOK; E MOLNAR
Journal:  Acta Microbiol Acad Sci Hung       Date:  1961

2.  Present position of immunization against poliomyelitis with live virus vaccines.

Authors:  A B SABIN
Journal:  Br Med J       Date:  1959-03-14

3.  Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter.

Authors:  M Benyesh-Melnick; J L Melnick; W E Rawls; I Wimberly; J B Oro; E Ben-Porath; V Rennick
Journal:  Am J Epidemiol       Date:  1967-07       Impact factor: 4.897

4.  Rct-marker tests on isolates from WM3 and Sabin type 3 attenuated poliovirus vaccines.

Authors:  M Böttiger
Journal:  Arch Gesamte Virusforsch       Date:  1968

Review 5.  A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine.

Authors:  V Vonka; Z Janda; J Simon; E Adam; M Stárek
Journal:  Prog Med Virol       Date:  1967

6.  Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus.

Authors:  Z Janda; E Adam; V Vonka
Journal:  Arch Gesamte Virusforsch       Date:  1967

7.  Antigenic studies on Sabin types 1 & 3 poliovaccine virus during 1 to 7 passages in the human intestinal tract.

Authors:  J Furesz; R E Armstrong; P Moreau; W Yarosh; F P Nagler
Journal:  Am J Epidemiol       Date:  1966-05       Impact factor: 4.897

8.  Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis.

Authors:  A B Sabin
Journal:  JAMA       Date:  1965-11-22       Impact factor: 56.272

9.  Antigenic segregation of type 3 poliovirus isolates related and unrelated to Sabin's vaccine strain with the use of modified Wecker and McBride techniques.

Authors:  J H Nakano; H M Gelfand; J T Cole
Journal:  Am J Epidemiol       Date:  1966-01       Impact factor: 4.897

10.  Serodifferentiation of type 3 poliovirus strains isolated 1960-1965 from patients and healthy vaccinees. Characterization of strains associated with disease in vaccinated persons and household contacts.

Authors:  R Deibel; D Macdonald
Journal:  Am J Epidemiol       Date:  1968-03       Impact factor: 4.897
View more
  1 in total

Review 1.  Questions regarding the safety and duration of immunity following live yellow fever vaccination.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2016-06-20       Impact factor: 5.683
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.